In order to explore the function of SIRT3 in prostate cancer, we first generated two SIRT3 stably overexpressed, castration-resistant prostate cancer (CRPC) cell lines that originally expressed low levels of SIRT3 (C42B-SIRT3 and PC3-SIRT3). The gene discussed is SIRT3; the disease is prostate carcinoma.